Oncozenge AB Cash Flow-to-Debt Ratio
Oncozenge AB cash flow-to-debt ratio. Oncozenge AB (ONCOZ) has a Cash Flow-to-Debt Ratio of -0.45x as of December 2025, meaning its operating cash flow of Skr-7.24 Million could theoretically repay 0% of its total liabilities (Skr15.92 Million) in one year. Check Oncozenge AB (ONCOZ) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Oncozenge AB (2020–2025)
Cash flow-to-debt ratio of Oncozenge AB from 2020 to 2025. Historical debt coverage capacity for Oncozenge AB across 6 annual periods. Check ONCOZ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Oncozenge AB Cash Flow-to-Debt Ratio by Year (2020–2025)
Oncozenge AB cash flow-to-debt ratio by year from 2020 to 2025. Year-by-year debt coverage analysis for Oncozenge AB. For the full cash flow conversion analysis, see Oncozenge AB (ONCOZ) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.82x | Skr-13.06 Million | Skr15.92 Million | ▲ +86.1% |
| 2024 | -5.91x | Skr-8.76 Million | Skr1.48 Million | ▲ +41.3% |
| 2023 | -10.05x | Skr-17.08 Million | Skr1.70 Million | ▼ -33.0% |
| 2022 | -7.56x | Skr-22.08 Million | Skr2.92 Million | ▼ -677.8% |
| 2021 | -0.97x | Skr-4.77 Million | Skr4.90 Million | ▼ -876118.1% |
| 2020 | 0.00x | Skr-1.00K | Skr9.01 Million | — |